search
Back to results

Direct Left Ventricular Rapid Pacing Via the Valve Delivery Guide-wire in TAVI (EASY TAVI)

Primary Purpose

Aortic Valve Stenosis

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
pacing catheter
valve delivery guidewire
Sponsored by
Groupe Hospitalier Mutualiste de Grenoble
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Aortic Valve Stenosis focused on measuring TAVI, aortic valve bioprothesis, TAVI simplification, aortic stenosis, rapid left ventricular pacing, TAVR

Eligibility Criteria

18 Years - 100 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Subject is eligible for a TAVI
  • Access considered for aortic valve bioprothesis delivery is transfemoral
  • Aortic valve bioprothesis considered is Edwards Sapien 3® et/ou XT®
  • Subject is ≥ 18 years of age
  • Subject has signed informed consent form

Exclusion Criteria:

  • Pregnancy
  • Subject already included in this study
  • Subject included in another study and whose inclusion in EASY TAVI implies a deviation in either study

Sites / Locations

  • CHU Clermont Ferrand
  • Centre Hospitalier Annecy Genevois
  • Clinique du Tonkin
  • Institut Mutualiste Montsouris
  • Groupement Hospitalier Mutualiste de Grenoble
  • Hôpital privé Jacques Cartier
  • Clinique Saint-Hilaire
  • Clinique Pasteur
  • Institut Arnault Tzanck

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Right ventricular pacing

Left ventricular pacing

Arm Description

Rapid pacing during TAVI is provided by a temporary pacing catheter placed in the right ventricle. An additional venous vascular access is required.

Rapid pacing during TAVI is provided by the valve delivery guidewire inserted into the left ventricle using two alligator clamps. One clamp is attached directly to the skin at the femoral entry site, the other is attached to the body of the valve delivery guidewire. No additional venous vascular access is required.

Outcomes

Primary Outcome Measures

Total TAVI procedural duration
Duration of TAVI procedure is calculated from the first puncture to the last sheath removal

Secondary Outcome Measures

Efficacy of the experimental technique to create a blood pressure drop reaching at least 60 mmHg (Ventricular stimulation efficiency)
Stimulation efficiency is defined as a drop in systolic blood pressure reaching at least 60 mmHg during the prolonged stimulation without loss of capture for more than 30s.
Incidence of the experimental technique on succes rate of the intervention, fluoroscopy time, radiation exposure, Major adverse cardiovascular event and tamponades (Safety)
Safety includes success of the intervention, fluoroscopy time, radiation exposure, Major adverse cardiovascular event and tamponades
Incidence of the experimental technique on direct and indirect costs (Cost-effectiveness)
Study costs includes direct costs (material used for the rapid pacing) and indirect costs (medical complications)

Full Information

First Posted
May 18, 2016
Last Updated
July 11, 2018
Sponsor
Groupe Hospitalier Mutualiste de Grenoble
Collaborators
Centre Recherche Cardio Vasculaire Alpes
search

1. Study Identification

Unique Protocol Identification Number
NCT02781896
Brief Title
Direct Left Ventricular Rapid Pacing Via the Valve Delivery Guide-wire in TAVI
Acronym
EASY TAVI
Official Title
Direct Left Ventricular Rapid Pacing Via the Valve Delivery Guide-wire in TAVI: a Randomized Study
Study Type
Interventional

2. Study Status

Record Verification Date
July 2018
Overall Recruitment Status
Completed
Study Start Date
May 12, 2017 (Actual)
Primary Completion Date
June 29, 2018 (Actual)
Study Completion Date
June 29, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Groupe Hospitalier Mutualiste de Grenoble
Collaborators
Centre Recherche Cardio Vasculaire Alpes

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to determine whether a left ventricular rapid pacing using the valve delivery guide-wire in transcatheter aortic valve implantation (TAVI) reduces the overall procedure duration in comparison with the conventional method.
Detailed Description
Use of temporary pacing via a right ventricular lead in TAVI is still mandatory to ensure transient cardiac standstill while predilatation is performed and the valve is being positioned and deployed. This requires an additional venous vascular access and a pacing catheter which are both likely to generate complications. This study compares the standard right ventricular rapid pacing to a new and simplified technique : a left ventricular rapid pacing is provided via the back-up 0.035 " guidewire. The cathode of an external pacemaker is placed on the tip of the 0.035" wire and the anode on a needle inserted into the groin. Insulation is ensured by the balloon or TAVI catheter.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aortic Valve Stenosis
Keywords
TAVI, aortic valve bioprothesis, TAVI simplification, aortic stenosis, rapid left ventricular pacing, TAVR

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
300 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Right ventricular pacing
Arm Type
Active Comparator
Arm Description
Rapid pacing during TAVI is provided by a temporary pacing catheter placed in the right ventricle. An additional venous vascular access is required.
Arm Title
Left ventricular pacing
Arm Type
Experimental
Arm Description
Rapid pacing during TAVI is provided by the valve delivery guidewire inserted into the left ventricle using two alligator clamps. One clamp is attached directly to the skin at the femoral entry site, the other is attached to the body of the valve delivery guidewire. No additional venous vascular access is required.
Intervention Type
Device
Intervention Name(s)
pacing catheter
Other Intervention Name(s)
transvenous stimulation electrode, pacing lead, pacing wire
Intervention Description
Rapid pacing during TAVI is required to ensure transient cardiac standstill while predilatation is performed and the valve is being positioned and deployed. In the right ventricular pacing arm, rapid pacing is provided by a standard right ventricular pacing catheter.
Intervention Type
Device
Intervention Name(s)
valve delivery guidewire
Intervention Description
Rapid pacing during TAVI is required to ensure transient cardiac standstill while predilatation is performed and the valve is being positioned and deployed. In the Left ventricular pacing arm, rapid pacing is provided via the valve-delivery guidewire inserted into the left ventricle. The cathode of an external pacemaker is placed on the external end of the guidewire using an alligator clamp. The TAVI catheter provides the necessary insulation. The anode is attached directly to the subcutaneous tissue at the femoral entry site (also using an alligator clamp).
Primary Outcome Measure Information:
Title
Total TAVI procedural duration
Description
Duration of TAVI procedure is calculated from the first puncture to the last sheath removal
Time Frame
1 month
Secondary Outcome Measure Information:
Title
Efficacy of the experimental technique to create a blood pressure drop reaching at least 60 mmHg (Ventricular stimulation efficiency)
Description
Stimulation efficiency is defined as a drop in systolic blood pressure reaching at least 60 mmHg during the prolonged stimulation without loss of capture for more than 30s.
Time Frame
1 month
Title
Incidence of the experimental technique on succes rate of the intervention, fluoroscopy time, radiation exposure, Major adverse cardiovascular event and tamponades (Safety)
Description
Safety includes success of the intervention, fluoroscopy time, radiation exposure, Major adverse cardiovascular event and tamponades
Time Frame
1 month
Title
Incidence of the experimental technique on direct and indirect costs (Cost-effectiveness)
Description
Study costs includes direct costs (material used for the rapid pacing) and indirect costs (medical complications)
Time Frame
1 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subject is eligible for a TAVI Access considered for aortic valve bioprothesis delivery is transfemoral Aortic valve bioprothesis considered is Edwards Sapien 3® et/ou XT® Subject is ≥ 18 years of age Subject has signed informed consent form Exclusion Criteria: Pregnancy Subject already included in this study Subject included in another study and whose inclusion in EASY TAVI implies a deviation in either study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Benjamin Faurie
Organizational Affiliation
Centre Recherche Cardio Vasculaire Alpes
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Thierry Lefèvre
Organizational Affiliation
Massy
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Clermont Ferrand
City
Clermont-Ferrand
State/Province
Auvergne-Rhône-Alpes
ZIP/Postal Code
63000
Country
France
Facility Name
Centre Hospitalier Annecy Genevois
City
Epagny
State/Province
Auvergne-Rhône-Alpes
ZIP/Postal Code
74370
Country
France
Facility Name
Clinique du Tonkin
City
Villeurbanne
State/Province
Auvergne-Rhône-Alpes
ZIP/Postal Code
69100
Country
France
Facility Name
Institut Mutualiste Montsouris
City
Paris
State/Province
Ile De France
ZIP/Postal Code
75014
Country
France
Facility Name
Groupement Hospitalier Mutualiste de Grenoble
City
Grenoble
State/Province
Isère
ZIP/Postal Code
38028
Country
France
Facility Name
Hôpital privé Jacques Cartier
City
Paris
State/Province
Massy
ZIP/Postal Code
91300
Country
France
Facility Name
Clinique Saint-Hilaire
City
Rouen
State/Province
Normandie
ZIP/Postal Code
76000
Country
France
Facility Name
Clinique Pasteur
City
Toulouse
State/Province
Occitanie
ZIP/Postal Code
31300
Country
France
Facility Name
Institut Arnault Tzanck
City
Saint-Laurent-du-Var
State/Province
Provence-Alpes-Côte d'Azur
ZIP/Postal Code
06721
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
24678937
Citation
Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK; U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014 May 8;370(19):1790-8. doi: 10.1056/NEJMoa1400590. Epub 2014 Mar 29.
Results Reference
background
PubMed Identifier
26292584
Citation
Arnold SV, Reynolds MR, Wang K, Magnuson EA, Baron SJ, Chinnakondepalli KM, Reardon MJ, Tadros PN, Zorn GL, Maini B, Mumtaz MA, Brown JM, Kipperman RM, Adams DH, Popma JJ, Cohen DJ; CoreValve US Pivotal Trial Investigators. Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial. JACC Cardiovasc Interv. 2015 Aug 17;8(9):1207-1217. doi: 10.1016/j.jcin.2015.04.018.
Results Reference
background
PubMed Identifier
12473543
Citation
Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002 Dec 10;106(24):3006-8. doi: 10.1161/01.cir.0000047200.36165.b8.
Results Reference
background
PubMed Identifier
14975485
Citation
Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, Bash A, Nusimovici D, Litzler PY, Bessou JP, Leon MB. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004 Feb 18;43(4):698-703. doi: 10.1016/j.jacc.2003.11.026.
Results Reference
background
PubMed Identifier
24235321
Citation
Eggebrecht H, Mehta RH, Kahlert P, Schymik G, Lefevre T, Lange R, Macaya C, Mandinov L, Wendler O, Thomas M. Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): insights from the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry. EuroIntervention. 2014 Dec;10(8):975-81. doi: 10.4244/EIJV10I8A165.
Results Reference
background
PubMed Identifier
27510946
Citation
Faurie B, Abdellaoui M, Wautot F, Staat P, Champagnac D, Wintzer-Wehekind J, Vanzetto G, Bertrand B, Monsegu J. Rapid pacing using the left ventricular guidewire: Reviving an old technique to simplify BAV and TAVI procedures. Catheter Cardiovasc Interv. 2016 Nov 15;88(6):988-993. doi: 10.1002/ccd.26666. Epub 2016 Aug 11.
Results Reference
background
PubMed Identifier
22551129
Citation
Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carrie D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R, Delpine S, Souteyrand G, Favereau X, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel JP, Bourlon F, Bertrand B, Van Belle E, Laskar M; FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012 May 3;366(18):1705-15. doi: 10.1056/NEJMoa1114705.
Results Reference
background
PubMed Identifier
18814234
Citation
Karagoz T, Aypar E, Erdogan I, Sahin M, Ozer S, Celiker A. Congenital aortic stenosis: a novel technique for ventricular pacing during valvuloplasty. Catheter Cardiovasc Interv. 2008 Oct 1;72(4):527-30. doi: 10.1002/ccd.21695.
Results Reference
background
PubMed Identifier
21075775
Citation
Lefevre T, Kappetein AP, Wolner E, Nataf P, Thomas M, Schachinger V, De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Serruys P, Wimmer-Greinecker G; PARTNER EU Investigator Group. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J. 2011 Jan;32(2):148-57. doi: 10.1093/eurheartj/ehq427. Epub 2010 Nov 12.
Results Reference
background
PubMed Identifier
20961243
Citation
Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010 Oct 21;363(17):1597-607. doi: 10.1056/NEJMoa1008232. Epub 2010 Sep 22.
Results Reference
background
PubMed Identifier
19213097
Citation
Navarini S, Pfammatter JP, Meier B. Left ventricular guidewire pacing to simplify aortic balloon valvuloplasty. Catheter Cardiovasc Interv. 2009 Feb 15;73(3):426-7. doi: 10.1002/ccd.21810. No abstract available.
Results Reference
background
PubMed Identifier
24657695
Citation
Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleiman NS, Heimansohn D, Hermiller J Jr, Hughes GC, Harrison JK, Coselli J, Diez J, Kafi A, Schreiber T, Gleason TG, Conte J, Buchbinder M, Deeb GM, Carabello B, Serruys PW, Chenoweth S, Oh JK; CoreValve United States Clinical Investigators. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014 May 20;63(19):1972-81. doi: 10.1016/j.jacc.2014.02.556. Epub 2014 Mar 19.
Results Reference
background
PubMed Identifier
21639811
Citation
Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011 Jun 9;364(23):2187-98. doi: 10.1056/NEJMoa1103510. Epub 2011 Jun 5.
Results Reference
background
PubMed Identifier
21747054
Citation
Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H, Eggebrecht H, Rubino P, Colombo A, Lange R, Schwarz RR, Wendler O. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011 Jul 26;124(4):425-33. doi: 10.1161/CIRCULATIONAHA.110.001545. Epub 2011 Jul 11.
Results Reference
background
PubMed Identifier
25787198
Citation
Walther T, Hamm CW, Schuler G, Berkowitsch A, Kotting J, Mangner N, Mudra H, Beckmann A, Cremer J, Welz A, Lange R, Kuck KH, Mohr FW, Mollmann H; GARY Executive Board. Perioperative Results and Complications in 15,964 Transcatheter Aortic Valve Replacements: Prospective Data From the GARY Registry. J Am Coll Cardiol. 2015 May 26;65(20):2173-80. doi: 10.1016/j.jacc.2015.03.034. Epub 2015 Mar 15.
Results Reference
background
PubMed Identifier
21641358
Citation
Wenaweser P, Pilgrim T, Roth N, Kadner A, Stortecky S, Kalesan B, Meuli F, Bullesfeld L, Khattab AA, Huber C, Eberle B, Erdos G, Meier B, Juni P, Carrel T, Windecker S. Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J. 2011 Jun;161(6):1114-24. doi: 10.1016/j.ahj.2011.01.025. Epub 2011 May 11.
Results Reference
background
PubMed Identifier
16145240
Citation
Vogel R, Meier B. Emergent mechanical and electrical guidewire pacing of the right ventricle for aystole in the cardiac catheterization laboratory. J Invasive Cardiol. 2005 Sep;17(9):490. No abstract available.
Results Reference
background
PubMed Identifier
31857014
Citation
Faurie B, Souteyrand G, Staat P, Godin M, Caussin C, Van Belle E, Mangin L, Meyer P, Dumonteil N, Abdellaoui M, Monsegu J, Durand-Zaleski I, Lefevre T; EASY TAVI Investigators. Left Ventricular Rapid Pacing Via the Valve Delivery Guidewire in Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2019 Dec 23;12(24):2449-2459. doi: 10.1016/j.jcin.2019.09.029. Epub 2019 Sep 28.
Results Reference
derived

Learn more about this trial

Direct Left Ventricular Rapid Pacing Via the Valve Delivery Guide-wire in TAVI

We'll reach out to this number within 24 hrs